CSIRO and Moderna launch five-year biosecurity partnership
CSIRO and Moderna will spend five years researching infectious diseases and mRNA technology. This will help Australia respond faster to biosecurity threats.
Australia's CSIRO has signed a partnership with Moderna. Moderna is a medicine company.
CSIRO and Moderna will develop faster responses to disease threats. The five-year collaboration focuses on infectious disease research and mRNA technology.
This technology uses genetic instructions to train your immune system. Moderna developed the COVID vaccine.
It is now testing an mRNA vaccine for bird flu. Defence Minister Richard Marles said this work strengthens Australia's ability to respond to biosecurity threats.
It helps the country respond quickly. The partnership will examine agricultural biosecurity protections.
It will cover Australia and the Pacific region. CSIRO scientists will learn from Moderna's research team.
- five years
- Partnership duration
- Australia and Pacific region
- Geographic scope
- bird flu
- Moderna's current vaccine trials
Why it mattersA faster response to disease outbreaks could save lives and prevent economic damage. Learning from Moderna helps Australia prepare for future pandemics.
AustraliaAustralian scientists gain access to leading mRNA expertise, and the agricultural sector gets new biosecurity protection across the region.
✓ Claims checked against the source. checked 2 h ago
Open this story in InSnip →
